Status:
COMPLETED
Contrast of Buffered Vs. Unbuffered Lidocaine in Bone Marrow Biopsies
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Oncology patients require numerous invasive procedures throughout their disease process including bone marrow biopsies (BMB). BMB.s are performed by a significant number of health care providers. One ...
Eligibility Criteria
Inclusion
- Any newly diagnosed patient at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute whose Hematologist or Oncologist has ordered them to undergo a bilateral bone marrow biopsy for diagnostic and /or treatment purposes.
- 18 years of age or older.
Exclusion
- Pregnant or Lactating women.
- Patients with allergies to local anesthetics.
- Patients requiring a unilateral bone marrow biopsy.
- Patients that cannot lie flat in either the supine or prone position.
- Patients that have used any of the following: narcotics, non-narcotic analgesia or an anti-anxiolytic medication on the same calendar day as the scheduled procedure. These medications will not be given to the participant at any time before or during the procedure.
- Patients on long-acting narcotic medication.
- Patients with neuropathy in the posterior iliac crest area
- Patients with a platelet count less than 20,000.
- Patients who are cognitively impaired or unable to self-report pain using the VAS.
- Patients with known bone metastasis.
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00456872
Start Date
December 1 2004
End Date
September 1 2007
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University James Cancer Hospital
Columbus, Ohio, United States, 43210